Pharmaceutical Executive
September 01, 2014
Special Sponsored Section
0
0
Spain's recession-battered pharma sector adapts to a changing market environment and repositions itself for a return to healthy growth through expanding opportunities abroad.
September 01, 2014
Column
0
0
The role of pharma medical affairs teams is taking on greater importance in the value chain.
September 01, 2014
Features
0
0
Leaders from industry, government, and the CRO community examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the leading exporter of finished pharmaceutical products.
September 01, 2014
Features
0
0
Defining the critical coaching steps necessary for top managers to realize their potential in an industry undergoing significant restructuring of human and financial capital.
September 01, 2014
Features
0
0
After a dip into negative territory in 2012, 2013 delivered a resurgence in sales revenues, but the turnaround only spotlights a larger trend: the growing divide between the big Pharmas and the more nimble players.
September 01, 2014
Column
0
0
Pharma hopes for a deal are fading as the once-hot TTIP talks seem to be on the fizzle in Europe.
September 01, 2014
From the Editor
0
0
Pharm Exec's latest Industry Audit sticks to the series' longtime standard of emphasizing transparent indicators of shareholder value.
September 01, 2014
Column
0
0
Expansion of drug discount program ignites lawsuits, policy disputes.